Category: Stock Market

One of the highest growth ASX 200 healthcare stocks on the market went into a trading halt on Thursday.

Neuren Pharmaceuticals Ltd (ASX: NEU) requested the trading halt before the market open today.

The company said it wanted time to analyse data from its Phase 2 clinical trial of its second drug candidate, NNZ-2591, in the treatment of Pitt Hopkins syndrome.

Neuren intends to prepare a statement announcing the top-line results shortly.

The ASX 200 healthcare stock will remain in a trading halt until either the announcement is released or trading commences on Monday.

What is Pitt Hopkins syndrome?

Neuren develops drugs for serious childhood neurological disorders that have no or limited approved treatments.

All of its drugs have ‘orphan drug’ designation in the United States, which gives Neuren access to incentives to support its work. It also has an orphan drug designation for NNZ-2591 in Europe.

Pitt Hopkins syndrome (PTHS) is a neurodevelopmental condition that causes developmental delays.

It causes moderate to severe intellectual disability, hyperventilation and/or breath-holding while awake, seizures, gastrointestinal issues, speech difficulties, and sleep disturbances.

Sufferers often have distinctive facial features and are sometimes misdiagnosed as suffering from autism.

Neuren says PTHS is caused by the loss of one copy, or a mutation, of the TCF4 gene on the 18th human chromosome. The incidence of PTHS is estimated at between 1 in 11,000 people and 1 in 41,000 people.

Previously, Neuren tested NNZ-2591 on mice with the tcf4 mutation for six weeks. The company said its drug “normalized the deficits in all the tests for hyperactivity, daily living, learning and memory, sociability, motor performance and stereotype”.

ASX 200 healthcare stock up 40% in 6 months

Neuren Pharmaceuticals has been a barnstorming stock of the ASX 200 over the past two years.

It was the ASX 200 healthcare stock of the year in 2023, with its share price skyrocketing 214%.

The road has been a little more challenging for the Neuren Pharmaceuticals share price over the past six months. However, it is still up by 39.56% to $20.71 today.

The latest news from Neuren Pharmaceuticals

Prior to today’s trading halt announcement, the last piece of price-sensitive news we received from Neuren Pharmaceuticals was on 9 May.

That’s when the company released its Q1 FY24 update on sales of its maiden drug, Daybue.

Daybue is a world-first drug treatment for Rett syndrome. It’s approved in the US for adults and pediatric patients aged two years and up.

ASX investors appeared underwhelmed by the progress of Daybue sales in the US. As a result, the ASX 200 healthcare stock lost 3.93% on the day of the release.

Q1 net sales of Daybue in the US totalled US$75.9 million, just missing the guidance range of US$76 million to US$82 million. It was also lower than the previous quarter’s net sales of US$87.1 million.

Neuren blamed the fallen sales on seasonal factors, including refills that were due in January and actioned in December before the holidays, and reduced Rett clinic days in January.

The full-year 2024 guidance for net sales is between US$370 million and US$420 million.

Another challenge for this ASX 200 healthcare stock over the past six months was a short seller’s report in February, which described Daybue as a “flop” amid “horror stories” of side effects.

Neuren’s response failed to stop the ASX 200 healthcare stock from losing its upward trajectory from there.

The post ASX 200 healthcare stock up 40% in 6 months halted ahead of major trial results appeared first on The Motley Fool Australia.

More reading

• ASX 200 shares vs. property: Which has performed better since the COVID crash?
• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today
• Guess which four ASX 300 shares were just re-rated by top brokers
• Brokers name 3 ASX shares to buy now

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

CSL Ltd (ASX: CSL) shares have a long history of delivering market-beating returns for investors.

For example, over the last 15 years, the biotechnology giant’s shares have generated an average total return of 16.55% per annum.

To put that into context, a $10,000 investment back in 2009 would have grown to be worth approximately $99,500 today.

And while the market has historically delivered a very solid 10% per annum return, CSL’s outperformance has led to significantly greater wealth creation than if you had just invested the same $10,000 into an index fund.

For instance, $10,000 compounding at 10% per annum would grow to become approximately $42,000 in 15 years.

That’s less than half the return of CSL shares during the same period. Clearly it has been a great stock to hold in your portfolio.

But does this remain the case today? Let’s see if CSL can be a market-beater again in the future.

Can CSL shares beat the market?

Analysts at Morgans are feeling very positive about the company’s outlook. So much so, CSL has been named on the broker’s best ideas list again this month. Morgans said:

While shares have struggled of late, we continue to view CSL as a key portfolio holding and sector pick, offering double-digit recovery in earnings growth as plasma collections increase, new products get approved and influenza vaccine uptake increases around ongoing concerns about respiratory viruses, with shares trading at 25x, a substantial discount (20%) to its long-term average.

The broker has an add rating and $315.40 price target on its shares. This implies potential upside of 12% for investors from current levels.

Bigger returns to come

Over at Macquarie, its analysts are even more bullish on CSL shares. Macquarie currently has an outperform rating and $330.00 price targets on them. This suggests that potential upside of almost 17% is possible over the next 12 months.

But the returns won’t stop there according to the broker. Macquarie is so positive on the medium term outlook for the key CSL Behring business that it sees scope for the CSL share price to climb beyond $500 within three years. If this proves accurate, it would mean a return of 77% from current levels.

While nothing is guaranteed in the investment world, it is fair to say that analysts are quite confident that CSL can continue its market-beating ways long into the future. Time will tell if that is the case.

The post Can CSL shares deliver market-beating returns for investors? appeared first on The Motley Fool Australia.

More reading

• Don’t get clever, just buy stability: 2 defensive ASX shares to buy now
• 4 ASX shares held by billionaire fund managers
• 5 ASX 200 blue chip shares to buy now
• Top brokers name 3 ASX shares to buy next week
• Buy, hold or sell these 3 ASX 200 healthcare shares: Experts

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is out of form and trading lower. At the time of writing, the benchmark index is down 0.45% to 7,813.5 points.

Four ASX shares that are not letting that hold them back are listed below. Here’s why they are rising:

Australian Ethical Investment Ltd (ASX: AEF)

The Australian Ethical share price is up 5% to $4.62. This follows news that the investment company has entered into a binding agreement to acquire the sustainable fixed income asset management business, Altius Asset Management, from Australian Unity. Once complete, it will see Australian Ethical grow its funds under management (FUM) from $10.3 billion to $12.3 billion. This will be an increase of 19%. Management highlights that the proposed acquisition is consistent with its strategy to serve the growing potential addressable market created by the structural drivers favouring responsible investing.

Cromwell Property Group (ASX: CMW)

The Cromwell Property Group share price is up over 7% to 46.7 cents. This morning, the property company announced that it has agreed to sell its European fund management platform and interests to Stoneweg for $457 million. Management notes that the transaction continues the company’s strategy to simplify the business and transition to a capital light fund management model. It also allows Cromwell to focus on its core competencies in Australia and New Zealand.

Smartpay Holdings Ltd (ASX: SMP)

The Smartpay share price is up 10% to $1.22. This follows news that the payments company has signed a contract with Cuscal Payments NZ. The contract will see Cuscal provide payment processing services to support Smartpay provide acquiring services in New Zealand. CEO Marty Pomeroy said: “This is a significant milestone in Smartpay’s ongoing partnership with Cuscal and the journey to becoming a trans-tasman instore payments provider, and realising a transformational opportunity for our organisation.”

Xero Ltd (ASX: XRO)

The Xero share price is up 9% to $135.07. Investors have been buying the cloud accounting platform provider’s shares following the release of its FY 2024 results. Xero reported a 22% increase in operating revenue to NZ$1.71 billion for the 12 months. This was underpinned by a 419,000 increase in subscribers to 4.16 million and a 14% lift in average revenue per user to NZ$39.29. On the bottom line, the company swung from a loss of NZ$133.5 million to a sizeable profit of NZ$174.6 million. Xero CEO, Sukhinder Singh Cassidy, said: “This result shows we’re doing what we said we’d do. We’ve delivered a strong and profitable FY24 result and Rule of 40 outcome, demonstrating our commitment to balancing growth and profitability.”

The post Why Australian Ethical, Cromwell Property, Smartpay, and Xero shares are surging appeared first on The Motley Fool Australia.

More reading

• Xero share price leaps 8% on staggering earnings upheaval
• 5 things to watch on the ASX 200 on Thursday
• 5 stellar ASX growth shares to buy for strong returns
• Here are the top 10 ASX 200 shares today
• Own Xero shares? Here’s what to expect from next week’s results

Motley Fool contributor James Mickleboro has positions in Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Australian Ethical Investment and Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Australian Ethical Investment. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Do you remember how the COVID-19 market crash began, with ASX 200 shares plummeting almost 700 points in just five trading days?

Oh, the shivers up my spine! And that was just the start of it, too.

ASX 200 shares vs. property during the COVID crash

The first case of COVID-19 was registered in Australia on 31 January 2020.

Just three weeks later on 21 February, there was fear in the share market.

The S&P/ASX 200 Index (ASX: XJO) closed at 7,139 points on Thursday, 20 February… and then began its month-long fall. The benchmark index hit its trough of 4,546 points on 23 March.

All up, ASX 200 shares cratered 2,593 points or 36.3% over those four-and-a-bit weeks.

That was a terrible month for investors and a scary time for all of us for many other reasons, too!

Meantime, in the property market…

Discussions among experts about potentially large price falls due to COVID-19 began in March 2020.

SQM Research director Louis Christopher said a 30% decline in Sydney and Melbourne home values was possible in his worst-case scenario.

AMP chief economist Dr Shane Oliver referred to Treasury forecasts of a potential explosion in unemployment to 10%, which he said could lead to 20% house price falls at worst (courtesy abc.net.au).

But as we now know, that didn’t eventuate.

At best, property could be described as experiencing a ‘blip’ compared to what happened to ASX 200 shares.

The national median value fell for five consecutive months in 2020, but only in small amounts.

According to CoreLogic data, the median value declined -0.4% in May, -0.7% in June, and -0.6% in July. It then fell a further -0.4% in August and -0.1% in September.

Shares vs. property: Which has done better since COVID?

In analysing shares vs. property and their performance since COVID-19 hit us, it is clear that ASX 200 shares have come out the winner if we take an overall view.

Eleanor Creagh, a senior economist at REA Group Ltd (ASX: REA), said PropTrack data covering the four years from March 2020 to 2024 shows a 39.9% uplift in the national home price.

Meantime, the ASX 200 has risen 50.2% from 31 March 2020 to 27 March 2024.

So, ASX 200 shares win from an overall perspective.

But as you’ll see below, some capital city and regional property markets did better than 50.2% growth.

So, it’s fair to say that both asset classes have delivered impressive gains since COVID-19.

Pandemic property boom

Emergency low interest rates, government stimulus payments such as Jobkeeper, and the ability to work from home, thanks to technology, enabled many homeowners to continue repaying their loans.

The banks offered loan repayment holidays to those doing it tough to limit arrears. A moratorium on evictions stopped landlords from evicting tenants who couldn’t pay their rent due to job losses.

Lockdowns prevented people from leaving their homes, and open homes were disallowed for periods.

These were some of the factors that kept the housing market from collapsing during the first year of the pandemic. After that, a boom ensued, and home values soared across the country.

The prolonged period of emergency low interest rates was an incredibly powerful factor in the boom.

Once-in-a-lifetime rock-bottom mortgage rates encouraged more people to upgrade their homes or buy more property investments after lockdowns were lifted.

A lack of stock for sale kept supply lower than demand, forcing prices higher across the nation.

Creagh notes several trends during the pandemic. These include regional property prices growing faster than capital city prices as thousands of people who could work from home left the major cities.

People also left expensive inner-city areas to buy larger and more affordable homes in city outskirts areas.

Creagh said:

At the very onset of the pandemic, there was a pause in the housing market as lockdown restrictions, closed borders and uncertainty weighed, with many thinking home prices would fall.

In fact, the opposite occurred. Housing demand surged, and along with record low interest rates and limited stock for sale, combined to drive a price boom that saw national prices growing at the third-fastest rate in Australia’s history.

After the pandemic boom, prices began to fall shortly after the Reserve Bank began increasing interest rates in May 2022. But this price moderation did not last long.

Strong population growth after the border reopened, continuing low stock for sale, a tight rental market and continuing low unemployment led to a new property growth cycle commencing in early 2023.

Creagh commented:

Net migration has hit record levels since the international borders reopened, and insufficient housing supply coupled with strong demand has offset the higher interest rate environment and deterioration in housing affordability.

Here is how property prices moved between March 2020 and 2024, according to REA’s PropTrack data.

Property market	Median home value	Price growth March 2020 – March 2024
Sydney	$1,069,000	34.7%
Melbourne	$802,000	17.2%
Brisbane	$801,000	63.1%
Adelaide	$723,000	64%
Perth	$660,000	57.3%
Hobart	$662,000	36.1%
Darwin	$482,000	25.1%
ACT	$827,000	37.4%
Regional New South Wales	$715,000	51.6%
Regional Victoria	$584,000	40.6%
Regional Queensland	$647,000	66.5%
Regional South Australia	$439,000	66.2%
Regional Western Australia	$496,000	55.5%
Regional Tasmania	$501,000	53.6%
Regional Northern Territory	$424,000	9.4%

V-shaped COVID recovery for ASX 200 shares

As stated earlier, ASX 200 shares fell 36.3% between 20 February and 23 March 2020.

Then began the recovery in a fairly pronounced V-shape, as shown in the chart below.

ASX 200 shares went from the trough of 4,546 points on 23 March to 6,198.6 points on 9 June. From there, the benchmark index moved sideways before a Santa Rally in November and December 2020.

The chart shows the journey from there through til today.

During the four-year period we are examining in this article, ASX 200 shares rose 50.2%.

Today, the ASX 200 shares index is 7,799.1 points, down 0.62%.

And a fun fact: the ASX 200 reached a new all-time high of 7,910.5 points on 1 April.

5 top rising ASX 200 shares over 4 years

Here are the ASX 200 shares that had the highest share price growth between 31 March 2020 and 31 March 2024, according to data from S&P Global Market Intelligence.

As you can see, ASX lithium shares and ASX uranium shares dominate the list.

ASX 200 share	Share price growth March 2020 – 2024
Paladin Energy Ltd (ASX: PDN)	2,696%
Pilbara Minerals Ltd (ASX: PLS)	2,153%
Neuren Pharmaceuticals Ltd (ASX: NEU)	2,043%
Liontown Resources Ltd (ASX: LTR)	1,646%
Boss Energy Ltd (ASX: BOE)	1,391%

Here are 9 other ASX 200 shares that you should have bought during the pandemic crash and held.

And here are some ASX shares that were COVID winners but crashed after life returned to normal.

The post ASX 200 shares vs. property: Which has performed better since the COVID crash? appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Thursday
• Here are the top 10 ASX 200 shares today
• Is the Paladin Energy share price overcooked at $17.40?
• These 2 ASX shares could win big time in the long term
• This top broker says the Pilbara Minerals share price is going to crash 35%

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended REA Group. The Motley Fool Australia has recommended REA Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) is having a tough time on Thursday. In afternoon trade, the benchmark index is down 0.5% to 7,808.4 points.

Four ASX shares that are falling more than most today are listed below. Here’s why they are dropping:

BHP Group Ltd (ASX: BHP)

The BHP Group share price is down 2.5% to $45.02. The market has responded negatively to news that the Big Australian has made a third offer for Anglo American plc (LSE: AAL). And while the offer has been rejected, the two parties will continue discussions for another week. Commenting on the rejection, the Anglo American board said: “The Board considered BHP’s Latest Proposal carefully, concluded it does not meet expectations of value delivered to Anglo American’s shareholders, and has unanimously rejected it.” It then adds that it is “willing to continue to engage with BHP and its advisers on this topic and has therefore requested a one week extension to the PUSU deadline which has been consented to by the Panel.”

Nufarm Ltd (ASX: NUF)

The Nufarm share price is down over 4% to $4.81. This follows the release of the agricultural chemicals company’s half year results. Nufarm reported revenue of $1.8 billion but a statutory net profit after tax of just $49 million. The good news is that a stronger second half is expected. Nufarm CEO, Greg Hunt, said: “Despite challenging conditions, Nufarm delivered a solid result for the first half of fiscal 24. For FY24 we expect EBITDA of between $350 million and $390 million. The mid-point of our guidance implies growth of 25% YoY in EBITDA in the second half of FY24.”

Peninsula Energy Ltd (ASX: PEN)

The Peninsula Energy share price is down almost 7% to 11.2 cents. This uranium miner is in the process of raising funds. Earlier this week, it revealed that strong demand and support was received from both new and existing global institutional and sophisticated investors as part of its fully underwritten $105.9 million equity raising. The retail component of this raising opened this morning. The proceeds are expected to fully fund operations at the flagship Lance Projects to sustainable free cash flow in 2025.

Regis Resources Ltd (ASX: RRL)

The Regis Resources share price is down 7.5% to $1.96. Investors have been selling Regis Resources and other ASX gold shares on Thursday following a sharp pullback in the gold price overnight. This has seen the S&P/ASX All Ordinaries Gold index lose almost 4% of its value today.

The post Why BHP, Nufarm, Peninsula Energy, and Regis Resource shares are sinking today appeared first on The Motley Fool Australia.

More reading

• Deal or no deal? Why the BHP share price is crumbling today
• 5 things to watch on the ASX 200 on Thursday
• BHP shares on watch after new $74b Anglo American takeover offer rejected
• 5 things to watch on the ASX 200 on Tuesday
• Here are the top 10 ASX 200 shares today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Four S&P/ASX 200 Index (ASX: XJO) shares just had their medium-term outlook slashed by leading brokers.

All four are household names.

And they each operate in different sectors.

Here’s why these ASX 200 shares may not perform quite as well over the coming 12 months as these brokers had previously been expecting.

(Broker data courtesy of The Australian.)

Four ASX 200 shares hit with downgrades

The first ASX 200 share getting hit with a downgrade is building materials company James Hardie Industries (ASX: JHX).

The James Hardie share price is up 22% over 12 months but down 20% in 2024. Shares are up 1.4% today at $47.84.

The company reported its full-year results on Tuesday. The past year’s results looked solid, with net sales up 4% year on year to US$3.94 billion. But the outlook for the year ahead looks to have led to the broker downgrades.

Earnings guidance for FY 2025 fell short of consensus expectations. And management noted that the outlook for its housing markets “continues to remain uncertain”.

With those results in mind, JP Morgan cut its rating for James Hardie shares to ‘neutral’ with a $50 price target, which is some 4% above current levels.

Macquarie also reduced its price target by 12% to $55. But the broker raised the ASX 200 share to an ‘outperform’ rating.

According to Macquarie (quoted by The Australian):

The group has made strong progress on cost and working capital reduction and improving the efficiency in procurement and R&D spend. These factors set the group up well for an eventual broad-based recovery.

Which brings us to the second ASX 200 share getting hit with a broker downgrade, Sonic Healthcare Ltd (ASX: SHL).

The Sonic Healthcare share price is down 28% over the past 12 months. Shares are up 3.5% today, however, at $25.40.

The medical diagnostic company released a disappointing earnings update on Tuesday, which saw management cut full year revenue and earnings guidance. The company flagged headwinds including inflation, adverse currency exchange rates, and delayed margin improvement initiatives.

On the back of this update, Citi cut its target price on Sonic Healthcare shares by 19% to $25.

Moving on, the third ASX 200 share getting a downgraded broker outlook is Telstra Group Ltd (ASX: TLS).

The Telstra share price is down 21% over the past 12 months. Shares are up 0.6% today at $3.44 apiece.

Australia’s biggest telco announced some significant organisational restructuring on Tuesday.

Among the bombshells, the ASX 200 share said that ongoing inflationary cost pressures will see 2,800 employees cut from its workforce.

And in a move that looks to have spurred the broker downgrade, Telstra said it was axing its annual inflation-linked postpaid mobile plan price reviews.

On the back of the update, Macquarie cut Telstra to a ‘neutral’ rating with a $3.70 price target.

The broker cited the removal of the inflation-linked price hikes as a “key negative” for the stock.

According to Macquarie analyst Darren Leung:

While Telstra indicated this provides them with greater flexibility to respond to market conditions, we view it as a negative for the industry when the market leader is no longer leading the upward price trajectory.

Put another way, pricing decisions are now increasingly dependent on Telstra’s peers, who have had a mixed track record.

Which brings us to the fourth ASX 200 share getting a broker downgrade, Westpac Banking Corp (ASX: WBC).

Westpac hasn’t released any price-sensitive reports since its half-year results on 6 May.

The Westpac share price is up 26% over the past 12 months. Shares are down 1.1% today at $26.78.

Despite today’s dip, Goldman Sachs believes that, like its peers, the big four bank’s valuations are still stretched. The broker cut Westpac shares to a ‘sell’ rating with a $24.10 price target.

Goldman Sachs analyst Andrew Lyons noted:

With earnings risks more balanced, valuations skewed heavily to the downside, and our analysis suggesting previous sector de-ratings not being catalysed by absolute or relative earnings downgrades, we take a more negative view on the banks.

The post Why these 4 ASX 200 shares just got downgraded by top brokers appeared first on The Motley Fool Australia.

More reading

• Dividend deals: 2 top ASX shares that still look undervalued
• An ASX dividend giant I’d buy over Westpac shares right now
• Top brokers name 3 ASX shares to buy today
• What are brokers saying about the Telstra share price after this week’s update?
• 5 things to watch on the ASX 200 on Wednesday

Citigroup is an advertising partner of The Ascent, a Motley Fool company. JPMorgan Chase is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, JPMorgan Chase, and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group and Telstra Group. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Betashares Nasdaq 100 ETF (ASX: NDQ) has just hit another all-time high today. During late morning trading on Thursday, shares in the exchange-traded fund (ETF) were peaking at $43.16.

As shown in the chart below, the ETF has lifted 15% in 2024 and 133% in the last five years.

Is the NDQ ETF a buy at an all-time high?

Of course, past performance is not a reliable indicator of future performance, but the chart above shows how the NDQ ETF has continued to eclipse its previous all-time highs.

Ultimately, a company’s financial and operational performance drives the share price over the long term. And the biggest businesses within the Betashares Nasdaq 100 ETF have succeeded in steadily growing earnings. These include Microsoft, Apple, Nvidia, Amazon, Broadcom, Meta Platforms and Costco.

I think the US technology stocks, including Alphabet, Microsoft, and Nvidia, have powered the ETF’s latest all-time high.

Indeed, Nvidia has reported its FY25 first quarter, which showed annual revenue growth of 262% to $26 billion, and adjusted earnings per share (EPS) jumped 461% to $6.12. These numbers beat market expectations.

Additionally, the NDQ ETF gives Aussies exposure to 100 globally leading US businesses that deliver products, services, and technological advancements that are changing how people work, learn, communicate, and entertain themselves. These are the sorts of companies we should want to own in our portfolio.

Finally, its annual management fee is 0.48%, which is cheaper than most active fund managers and, therefore, relatively appealing.

Does the valuation make sense?

According to BetaShares, at the end of April 2024, the NDQ ETF was trading on a forward price/earnings (P/E) ratio of 24.6x, which is higher than other share markets like Australia and the United Kingdom.

However, the large US tech names have delivered long-term earnings growth, which the market continues to underestimate. I think a higher valuation is justified if future earnings growth is (expected to be) strong.

The US share market could be volatile in the next year or even the next four years. But if profit keeps rising over the rest of the decade, the NDQ ETF can generate adequate returns to 2030.

While I’d prefer to invest in the Betashares Nasdaq 100 ETF at a lower price, I still think its five-year return can outperform the S&P/ASX 200 Index (ASX: XJO).

The post Should you buy Betashares Nasdaq 100 ETF (NDQ) at an all-time high? appeared first on The Motley Fool Australia.

More reading

• 3 excellent ASX ETFs for beginner investors to buy
• 3 reasons the Betashares Nasdaq 100 ETF (NDQ) is a great ASX ETF pick
• Why these ASX ETFs could be fantastic buy and hold options
• 2 ASX ETFs to buy and hold forever in your investment portfolio
• 5 ASX ETFs to invest $10,000 into next week

Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool’s board of directors. Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet, Amazon, BetaShares Nasdaq 100 ETF, Costco Wholesale, Meta Platforms, Microsoft, and Nvidia. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool Australia has positions in and has recommended BetaShares Nasdaq 100 ETF. The Motley Fool Australia has recommended Alphabet, Amazon, Meta Platforms, Microsoft, and Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Sayona Mining Ltd (ASX: SYA) share price is charging higher today.

Shares in the S&P/ASX 300 Index (ASX: XKO) lithium stock closed yesterday at 4.2 cents. In late morning trade on Thursday, shares are swapping hands for 4.4 cents apiece, up 4.8%.

For some context, the ASX 300 is down 1.0% at this same time.

Here’s what’s spurring investor interest today.

What’s boosting the ASX lithium share?

The Sayona Mining share price is smashing the benchmark today after the miner reported it has kicked off reverse circulation (RC) drilling at its Tabba Tabba Lithium Project, located in Western Australia.

Sayona is exploring a region where air core drilling previously identified high-potential pegmatite systems. RC drilling will enable the miner to drill significantly deeper.

The initial campaign comprises more than 2,000 metres of RC drilling across 14 holes. Sayona plans to conduct additional drilling throughout 2024 as it gains more geological information across the prospective area.

On the funding front, Sayona Mining could be getting a boost after the lithium miner reported it had secured a $180,000 co-funding grant from the WA Government’s Exploration Incentive Scheme (EIS).

Sayona said the government grant will help finance innovative exploration drilling in the search for flat lying spodumene pegmatite systems within the Tabba Tabba lease.

According to the ASX lithium stock:

Flat lying pegmatite systems often have limited surface expression and require a systematic exploration approach to best focus drilling into the most prospective target areas.

Sayona is advancing this process, being guided by gravity data, mapping, rock and soil sampling and drill information.

What did management say?

Commenting on the drill campaign sending the Sayona Mining share price sharply higher today, CEO James Brown said:

We are excited to have commenced RC drilling over the highly prospective Tabba Tabba lease which has known lithium mineralisation in close proximity and along strike.

Previous soil sampling and air core drilling identified areas of anomalous geochemistry that have been confirmed to also contain gravity features of significance. We now intend to test these targets with RC and possibly diamond drilling as supported by results.

We are highly committed to our wholly owned Western Australian lithium assets and intend to continue an active exploration program over the 2024 field season.

Sayona Mining share price snapshot

While today’s gains will be most welcomed by shareholders, the Sayona Mining share price is still down a precipitous 80% from this time last year.

The post Why did the Sayona Mining share price just leap 5%? appeared first on The Motley Fool Australia.

More reading

• These are the 10 most shorted ASX shares
• Down 80% in a year, are Sayona Mining shares now a buy?
• Why ANZ, Fletcher Building, Macquarie, and Sayona Mining shares are dropping today
• What’s happening with the Sayona Mining share price on Monday?
• These are the 10 most shorted ASX shares

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The BHP Group Ltd (ASX: BHP) share price is taking a tumble today.

Shares in the S&P/ASX 200 Index (ASX: XJO) mining giant closed yesterday trading for $46.24. In morning trade on Thursday, shares are swapping hands for $44.96, down 2.8%.

For some context, the ASX 200 is down 0.9% at this time.

BHP’s underperformance today comes following the latest developments in its ongoing multi-billion takeover efforts of Anglo American (LSE: AAL).

What’s happening with the Anglo American takeover?

The BHP share price is under selling pressure after the ASX 200 miner reported that it had lobbed a third improved takeover offer for Anglo American. And that this offer, too, was swiftly rejected by Anglo’s board.

BHP announced its first takeover bid back on 26 April.

The big Aussie miner is mostly interested in Anglo copper assets. Should BHP succeed in its acquisition, it will become the world’s top copper producer. BHP has indicated it will likely divest some of Anglo’s assets, like its South African platinum and iron ore projects.

The first takeover offer was rejected as undervaluing Anglo’s assets and growth prospects and being too complex. The BHP share price initially fell on that news as well.

On 14 May BHP reported a sweetened offer valued at around $64 billion. This was also quickly waved off by Anglo’s board.

This third, and likely final, offer is valued at $59.64 per Anglo American share, a hefty premium to Anglo American’s recent share price. The new offer equates to around $74 billion.

“BHP’s revised proposal will offer immediate value for Anglo American shareholders and allow them to benefit from the long-term value generation of the combined group,” BHP CEO Mike Henry said.

But Anglo American chairman Stuart Chambers is not convinced. “The board is confident in Anglo American’s standalone future prospects,” he said.

But that doesn’t mean a deal is off the table.

If Henry’s goal was to get negotiations rolling in earnest, it looks like he may have scored.

According to Chambers:

The board is willing to continue to engage with BHP and its advisers on this topic and has therefore requested a one-week extension to the PUSU deadline which has been consented to by the panel.

The one-week extension moves the new takeover deadline to 29 May.

“BHP looks forward to engaging with the board of Anglo American to explore this unique and compelling opportunity to bring together two highly complementary, world class businesses,” Henry said.

Commenting on the developments pressuring the BHP share price today, James Whiteside, metals and mining corporate research director at Wood Mackenzie said (quoted by Bloomberg), “The companies believe that they’re getting closer. Anglo has probably signposted what needs to happen to get it over the line.”

BHP share price snapshot

The BHP share price is up 3% over the past 12 months.

The post Deal or no deal? Why the BHP share price is crumbling today appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Thursday
• BHP shares on watch after new $74b Anglo American takeover offer rejected
• ASX 200 mining stocks flying higher on ‘most relaxed’ Chinese stimulus ever
• BHP shares charging higher as the clock ticks down on the Anglo American takeover
• ASX 200 mining shares charging higher amid China’s $210 billion cash injection

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Xero Ltd (ASX: XRO) share price is moving with gusto this morning after releasing its full-year results for FY24.

An hour into trade, the cloud-based accounting software company shares are up 7.6% to $133.49. The move starkly contrasts the 1.02% slump in the S&P/ASX 200 Index (ASX: XJO) after the US Federal Reserve revealed it had contemplated more interest rate rises.

So, what about Xero’s results enable its share price to perform while the rest of the market is struggling?

Profitable growth sparks Xero share price

Xero shareholders are celebrating this morning amid the company’s latest result. Here’s a look at the key numbers driving today’s excitement:

• Operating revenue up 22% year-on-year to NZ$1.71 billion
• Subscribers grew by 419,000 to 4.16 million
• Average revenue per user (ARPU) up 14% to NZ$39.29
• Gross margin up from 87.3% to 88.2%
• Net profit after tax (NPAT) swinging to NZ$174.6 million from NZ$113.5 million loss

Xero’s ability to balance revenue growth and profitability in FY24 is significant after years of lacking the latter. Importantly, the company has now achieved the Rule of 40 — a metric that implies a software company’s revenue growth and free cash flow margin should be 40% or more for a healthy business.

The company noted that it focused on balancing subscriber additions with ARPU during FY24. This might explain the 11% reduction in net subscriber additions compared to FY23. However, the positive is that Xero’s gross margin is improving while it manages its cost to serve customers.

Furthermore, Xero implemented price changes during FY24, boosting ARPU. Despite increasing prices, the 0.99% monthly churn rate is a positive indicator of product stickiness.

What did management say?

Xero CEO Sukhinder Singh Cassidy touted the full-year result, stating:

This result shows we’re doing what we said we’d do. We’ve delivered a strong and profitable FY24 result and Rule of 40 outcome, demonstrating our commitment to balancing growth and profitability.

We have a clear and focused strategy to win on purpose, and Xero is positioned well as we move into FY25.

Australia and New Zealand continue to be strong markets for the accounting platform. Xero achieved 22% revenue growth across the two countries, growing its subscriber count in the region to 2.4 million.

Meanwhile, revenue in its international markets (the United Kingdom, North America, and the Rest of the World) rose 24% to NZ$734.9 million. The company has 1.8 million subscribers in these expanding markets.

The road ahead

No light was shed on future earnings or revenue estimates for FY25. However, Xero expects total operating expenses as a percentage of revenue to be approximately 73% in the next financial year.

Product design and development costs are also forecast to be a larger portion of revenue.

Xero share price in review

The Xero share price is up 20% over the past 12 months. However, it was a considerably different story towards the end of last year.

Shares in the software company fell as low as roughly $70 apiece. Yet, positive sentiment has since returned to the technology sector.

The post Xero share price leaps 8% on staggering earnings upheaval appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Thursday
• 5 stellar ASX growth shares to buy for strong returns
• Here are the top 10 ASX 200 shares today
• Own Xero shares? Here’s what to expect from next week’s results
• Brokers name 2 rapidly growing ASX 200 tech stocks to buy

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.